Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Green Flags for Pfizer's Future

TheMotleyFool

0 0

Will pharma giant Pfizer (NYSE: PFE) run out of steam? The company's shares have soundly outperformed the market in the past year, mainly due to its COVID-19 vaccine, Comirnaty, which it developed in collaboration with BioNTech. However, investors may worry that once Pfizer's coronavirus tailwind comes to a halt, the company will see much darker days.

This could put downward pressure on the company's shares. While that's a legitimate worry, there are excellent reasons to be optimistic about Pfizer's future. Here are just two of them.